6/22
07:19 am
traw
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program [Yahoo! Finance]
Low
Report
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program [Yahoo! Finance]
6/22
07:00 am
traw
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
Medium
Report
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
6/18
10:00 am
traw
Traws Pharma (TRAW) was given a new $1.00 price target by HC Wainwright. They now have a "negative" rating on the stock.
Medium
Report
Traws Pharma (TRAW) was given a new $1.00 price target by HC Wainwright. They now have a "negative" rating on the stock.
6/18
08:22 am
traw
Traws Pharma (TRAW) had its "neutral" rating reaffirmed by HC Wainwright.
Low
Report
Traws Pharma (TRAW) had its "neutral" rating reaffirmed by HC Wainwright.
6/15
09:00 am
traw
Traws Pharma (TRAW) was downgraded by LADENBURG THALM/SH SH from "buy" to "neutral".
High
Report
Traws Pharma (TRAW) was downgraded by LADENBURG THALM/SH SH from "buy" to "neutral".
6/15
08:00 am
traw
Traws Pharma (TRAW) was downgraded by Citigroup Inc. to "neutral".
High
Report
Traws Pharma (TRAW) was downgraded by Citigroup Inc. to "neutral".
6/12
08:11 pm
traw
Why Did TRAW Stock Slump 28% After Hours? [Yahoo! Finance]
High
Report
Why Did TRAW Stock Slump 28% After Hours? [Yahoo! Finance]
6/12
05:48 pm
traw
Traws Pharma Provides Regulatory Update on Influenza Program [Yahoo! Finance]
High
Report
Traws Pharma Provides Regulatory Update on Influenza Program [Yahoo! Finance]
6/12
05:30 pm
traw
Traws Pharma Provides Regulatory Update on Influenza Program
High
Report
Traws Pharma Provides Regulatory Update on Influenza Program
5/31
06:02 am
traw
Traws Pharma (TRAW) was downgraded by
Weiss Ratings from "sell (d)" to "sell (e+)".
Low
Report
Traws Pharma (TRAW) was downgraded by
Weiss Ratings from "sell (d)" to "sell (e+)".
5/27
09:16 am
traw
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks [Yahoo! Finance]
Medium
Report
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks [Yahoo! Finance]
5/27
08:45 am
traw
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
Medium
Report
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
5/20
08:00 am
traw
Traws Pharma (TRAW) had its "buy" rating reaffirmed by HC Wainwright. They now have a $8.00 price target on the stock.
Low
Report
Traws Pharma (TRAW) had its "buy" rating reaffirmed by HC Wainwright. They now have a $8.00 price target on the stock.
5/17
06:01 am
traw
Traws Pharma (TRAW) was downgraded by
Weiss Ratings from "sell (d+)" to "sell (d)".
Medium
Report
Traws Pharma (TRAW) was downgraded by
Weiss Ratings from "sell (d+)" to "sell (d)".
5/15
07:00 am
traw
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
High
Report
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
5/8
07:30 am
traw
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
High
Report
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections